Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $59.7 million.

  • Select Medical Holdings' Cash & Equivalents fell 6863.5% to $60.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.1 million, marking a year-over-year decrease of 6863.5%. This contributed to the annual value of $59.7 million for FY2024, which is 1341.77% up from last year.
  • According to the latest figures from FY2024, Select Medical Holdings' Cash & Equivalents is $59.7 million, which was up 1341.77% from $52.6 million recorded in FY2023.
  • Over the past 5 years, Select Medical Holdings' Cash & Equivalents peaked at $577.1 million during FY2020, and registered a low of $52.6 million during FY2023.
  • Over the past 5 years, Select Medical Holdings' median Cash & Equivalents value was $74.3 million (recorded in 2021), while the average stood at $172.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 7180.47% in 2020, then crashed by 8712.27% in 2021.
  • Over the past 5 years, Select Medical Holdings' Cash & Equivalents (Annual) stood at $577.1 million in 2020, then plummeted by 87.12% to $74.3 million in 2021, then skyrocketed by 31.75% to $97.9 million in 2022, then crashed by 46.24% to $52.6 million in 2023, then rose by 13.42% to $59.7 million in 2024.
  • Its Cash & Equivalents was $59.7 million in FY2024, compared to $52.6 million in FY2023 and $97.9 million in FY2022.